AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform.
AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform that looks and acts like a real nerve. The company empowers advancements in human neuroscience and accelerates the drug development process through its drug discovery platforms, NerveSim and BrainSim.AxoSim was founded in 2014 and is based in New Orleans, Louisiana.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 10, 2021 | Series Unknown | $6.05M | — | — | — | Detail |
May 28, 2021 | Series A | — | 1 | — | — | Detail |
Nov 5, 2020 | Private Equity(PE) | — | 2 | — | — | Detail |
Jun 1, 2019 | Seed | — | 1 | — | — | Detail |
Mar 7, 2019 | Series Unknown | $1.13M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |
New Orleans BioFund | — | Series A |
Benson Capital Partners | — | Private Equity(PE) |
Jefferson Capital Partners | — | Private Equity(PE) |
Great Stuff Ventures | — | Series Unknown |
National Institutes of Health | — | Grant |
Lagniappe Angels | — | Seed |
Abstraction Ventures | — | Seed |
Laconia Ventures | — | Seed |
Center for the Advancement of Science in Space | — | Grant |